Zhefeng Li
Materials Science · The Ohio State University
Publications
59
Citations
2,179
Est. group size
~1
Recurring co-author estimate
Active years
22
Publishing since 2005
This publication record appears to span several unrelated fields, including single-cell and spatial transcriptomics studies of ovarian cancer, RNA nanoparticle engineering for cancer therapy delivery, organic chemistry reactions (catalysis and hydrochlorination), and even unrelated topics like wooden building weathering and stock market analysis. Because the topics are so varied and the estimated recurring co-author group size is minimal, this record likely reflects contributions from multiple distinct researchers who share the same name rather than one cohesive research program. Prospective students should independently verify which specific line of work and institutional affiliation matches the person they intend to contact.
Publication output rose from a low base before 2020 to a peak in 2021 and has since gradually declined to a steadier but lower rate of about 4-5 papers per year.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Exhausted CD8⁺ T cells promote ovarian cancer immunosuppression via CCL3-Driven M2 macrophage polarization
Cell Death and Disease · 2026
- Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer
International Immunopharmacology · 2025
- Single-cell transcriptomics identify a chemotherapy-resistance related cluster overexpressed CLIC3 in ovarian cancer
Discover Oncology · 2025
- Two-Dimensional Liquid Chromatography Method for Assembly Homogeneity Analysis and Mass Spectrometric Characterization of RNA Nanoparticles
ACS Applied Bio Materials · 2025
- Exhausted CD8⁺ T Cells Promote Ovarian Cancer Immunosuppression via CCL3-Driven M2 Macrophage Polarization
Research Square · 2025
- Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer
Journal of Cancer · 2024
- Conversion of Chemical Drugs into Targeting Ligands on RNA Nanoparticles and Assessing Payload Stoichiometry for Optimal Biodistribution in Cancer Treatment
RNA NanoMed · 2024
- Markovnikov Hydrochlorination of Unactivated Alkenes with FeCl<sub>3</sub> via a HAT/XAT Sequence
Organic Letters · 2024
- Weathering Characterization and Degradation Analysis of Landscape Wooden Buildings in Semi-Arid and Sandy Area
Journal of Architectural Research and Development · 2024
- Russia-Ukraine War – The Impact of Energy Market Fluctuation on the US Stock Market
Advances in Economics Management and Political Sciences · 2024
- Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer
Clinical and Translational Medicine · 2023
- Single-cell transcriptomics in ovarian cancer identify a metastasis-associated cell cluster overexpressed RAB13
Journal of Translational Medicine · 2023
- Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
Molecular Therapy — Nucleic Acids · 2023
- Convergent synthesis of triarylamines <i>via</i> Ni-catalyzed dual C(sp <sup>2</sup> )–H amination from benzamides with benzohydroxamic acids
Chemical Communications · 2023
- Scene Setting and Artistic Expression in Film Based on Landscape Vision
2023
- Cell Death and Disease×2
- Journal of Translational Medicine×2
- Figshare×2
- Nature Nanotechnology×1
- Scientific Reports×1
- Michael F. Tweedle
Materials Science · The Ohio State University
- Krishan Kumar
Materials Science · The Ohio State University
- Fengmei Pi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ashweta Sahni
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Congcong Xu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile